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Abstract
Background: A substantial literature supports antidiabetic properties of the lanosteryl triterpene (methyl-3β-
hydroxylanosta-9,24-dien-21-oate, RA-3) isolated from Protorhus longifolia stem bark. However, the molecular
mechanism(s) associated with the antihyperglycemic properties of the triterpene remained to be explored. The
current study aimed at investigating the molecular mechanism(s) through which RA-3 improves insulin signaling
in streptozotocin-induced type 1 diabetic rats.
Methods: The type 1 diabetic rats were treated daily with a single oral dose of RA-3 (100 mg/kg) for 28 days.
The rats were then sacrificed, and blood, skeletal muscle and pancreases were collected for biochemical, protein
expression and histological analysis, respectively.
Results: Persistently high blood glucose levels in the diabetic control rats significantly increased expression of
IRS-1Ser307 while the expression of p-Akt Ser473, p-GSK-3β Ser9, GLUT 4 and GLUT 2 were decreased. However, enhanced
muscle insulin sensitivity, which was indicated by a decrease in the expression of IRS-1ser307 with a concomitant increase
in the p-AktSer473, p-GSK-3β Ser9, GLUT 4 and GLUT 2 expression were observed in the diabetic rats treated with RA-3. The
triterpene-treated animals also showed an improved pancreatic β-cells morphology, along with increased C-
peptide levels. An increase in the levels of serum antioxidants such as catalase, superoxide dismutase, and
reduced glutathione was noted in the rats treated with the triterpene, while their serum levels of interleukin-6
and malondialdehyde were reduced.
Conclusions: It is apparent that RA-3 is able to improve the insulin signaling in type 1 diabetic rats. Its beta
(β)-cells protecting mechanism could be attributed to its ability to alleviate inflammation and oxidative stress
in the cells.
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Background
Type 1 diabetes mellitus (T1DM) is a multifactorial disease
that is characterized by insulin deficiency due to destruc-
tion of the insulin producing pancreatic beta (β)-cells. To
date, the exact causes of T1DM remain unknown. How-
ever, its onset is linked to an autoimmune attack on the
body’s own pancreatic β-cells as a result of environmental
stimuli on genetically predisposed individuals. T1DM
which is common amongst young children and adults,
accounts for 5–10% of diabetes cases world-wide [1, 2].
According to the latest statistical report from the Center
of Disease Control and Prevention (CDC, 2017), T1DM
affects 80,000 children annually and this number is ex-
pected to increase by 1.4% each year [3]. Due to early
onset and longer duration of the disease, affected individ-
uals are at increased risk of developing cardiac failure at a
young age [4]. This does not only place a financial burden
on individual households, but also on the countries’ health
system budgets.
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Insulin secretion and action are crucial in maintaining
glucose homeostasis, which is mediated through transloca-
tion of glucose transporters (GLUTs). Skeletal muscle is
responsible for 75% of insulin-mediated glucose disposal [5]
through activation of the phosphatidylinositol 3-kinase
(PI3-K)/protein kinase B (2) (Akt2) pathway and subse-
quent translocation of GLUT 4 to the plasma membrane
[6]. Persistent hyperglycemia or glucotoxicity observed in
diabetic patients, as a result of insulin signaling impair-
ment, is the underlying cause of various diabetic compli-
cations. This impairment is known to be concomitant to
oxidative stress and an augmented pro-inflammatory re-
sponse [7].
Though regular intravenous insulin injection is used to
manage T1DM, this management strategy neither cures
nor prevents onset of diabetes-induced complications.
Thus, more effective treatment regimens are required
in a quest to prevent, delay or more effectively treat the dis-
ease. Therefore, there is a growing interest in plant-derived
bioactive compounds as potential candidates in the devel-
opment of drug formulations with multiple targets to com-
bat diabetes and its associated complications.
Various in vitro and in vivo studies have shown that
triterpenes, a diverse group of natural compounds, have
the ability to inhibit intestinal glucose absorption [8–10]
and supress raised blood glucose levels through increased
insulin secretion and cellular glucose uptake in peripheral
tissues [11, 12]. A lanosteryl triterpene (RA-3, Fig. 1) iso-
lated from Protorhus longifolia (Benrh.) Engl. (Anacardia-
ceae) stem bark has been reported to possess hypoglycemic
properties, which are also associated with stimulation of
cellular glucose uptake [13] and improved glucose tolerance
[14, 15]. However, the molecular mechanism(s) associated
with these antidiabetic properties of the compound
remained to be elucidated. Therefore, this study was
set out to explore the molecular mechanism(s) through
which RA-3 exerts its hypoglycemic effect. Its effect on per-
ipheral insulin signaling in skeletal muscle of STZ-induced
type 1 diabetic rats was investigated in this study.
Methods
Extraction and isolation of RA-3
Fresh stem bark of Protorhus longifolia (specimen vou-
cher number RA01UZ) was collected from KwaHlabisa,
KwaZulu-Natal (KZN), South Africa. The plant was
verified by Dr. N.R. Ntuli from the Botany Department,
University of Zululand, South Africa. The plant material
was then air-dried and ground to powder. The targeted
lanosteryl triterpene, RA-3 (Fig. 1), was extracted and
isolated from the chloroform extract of P. longifolia
using chromatographic techniques as previously reported
[13, 16]. Spectroscopic (IR, NMR) data analysis was used
to confirm the chemical structure of the compound.
Induction of type 1 diabetes
Approval for use of laboratory animals (Rattus norvegicus)
and experimental procedures was granted by the University
of Zululand research ethics committee (ethical clearance
number: UZREC 171110–030 PGM 2016/329). Male Spra-
gue-Dawley rats (n = 20, 150–200 g) were obtained from
the Biochemistry and Microbiology Department, University
of Zululand. The animals were maintained under standard
conditions (12-h light/dark cycle, relative humidity, ~ 50%,
and temperature, 23–25 °C). Before commencement of ex-
perimental procedures, rats were acclimatized for five days
with free access to water and pelleted rat feed, ad libitum.
T1DM was induced by giving the rats a single intraperito-
neal injection of streptozotocin (STZ) solution (60 mg/kg).
Five days after the STZ injection, blood samples were ob-
tained by tail prick for blood glucose measurement. The
Fig. 1 Chemical structure of lanosteryl triterpene (RA-3)
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fasting blood glucose level was measured with ACCU
TREND PLUS® glucometer (Roche Diagnostics, Mannheim,
Germany). The rats with the fasting blood glucose levels
higher than or equal to 11 mmol/L were considered dia-
betic and they were used in the study.
Preparation of RA-3 solution
RA-3 was dissolved in Tween 20 (2%) to prepare a work-
ing solution of 100 mg/kg body weight of the rat. The pre-
pared dosage was based on previous studies performed in
our laboratory [14, 16].
Treatment of diabetic animals with RA-3
STZ-induced diabetic rats were randomly divided into
three groups with each group consisting of five animals
(n = 5). The animals were then orally administered with
the drugs or carrier solvent as follows: (I) diabetic con-
trol group was given Tween 20 (2% diluted with distilled
water); (II) diabetic animals treated with RA-3 (100 mg/kg);
and (III) diabetic animals treated with metformin
(100 mg/kg). The normal control group (IV) was given an
equivalent volume of distilled water. The animals received
an oral single dose of the RA-3 and metformin (standard
antidiabetic drug) daily for 28 days. Fasting blood glucose
levels of the rats were measured at seven days intervals
using the ACCUTREND PLUS® glucometer (Roche
Diagnostics, Mannheim, Germany) for the full duration
of the experimental period. Upon completion of the ex-
periment, the animals were fasted overnight, and then
placed in an induction chamber were it was anesthetized
by inhalation (2% isoflurane mixed with 98% Oxygen).The
loss of sensation was further confirmed by the pedal with-
drawal reflex before any procedure was performed. Blood
from the animals was collected by cardiac puncture for
serum analysis. Thereafter, the pancreas, liver and skeletal
muscles were harvested for histology and western blot
analysis, respectively.
Biochemical analysis of serum antioxidants,
malondialdehyde, interleukin-6 and C-peptide levels
Blood samples were centrifuged (Eppendorf® MiniSpin®
5454 Micro centrifuge, Merck) at 4 °C for 10 min at
1200 rpm. Serum was then collected into fresh tubes and
stored at − 80 °C until required. The serum levels of cata-
lase (CAT), superoxide dismutase (SOD), reduced glutathi-
one (GSH) and malondialdehyde (MDA) were measured
using commercially available assay kits from Sigma-Aldrich
(St. Louis, MO, USA). An enzyme-linked immunosorbent
assay (ELISA) kit obtained from Sigma-Aldrich Co. Ltd.
(Steinheim, Germany) was used to measure the serum
interleukin-6 (IL-6) level. Standard clinical laboratory
(Global Clinical & Viral Laboratory, Richards Bay, SA)
procedures were followed to measure the serum level
of C-peptide.
Hematoxylin and eosin stain of pancreas
The excised pancreatic tissues were fixed in neutral buff-
ered formalin (10%) until they were required for histo-
logical analysis. The formalin fixed tissues were routinely
processed by a Leica TP 1020 automated processor (Leica
Biosystems, Buffalo Grove, IL, USA) and embedded in
paraffin wax. Tissues were sectioned and attached to ami-
nopropyltriethoxysilane coated glass slides, after which
they were stained with hematoxylin and eosin [15]. Exam-
ination of the slides was performed by an independent
Pathologist without prior knowledge of the experimental
groups (Vet Diagnostix Laboratories, Pietermaritzburg,
South Africa).
Western blot analysis
To investigate effect of RA-3 on some known proteins
involved in insulin signaling pathway, immunoblots
against IRS-1ser307, p- AktSer473, p- GSK-3βSer9, GLUT 4
and GLUT 2 were performed. Snap frozen skeletal muscle
and liver tissues (100 mg each) were separately lysed in lysis
buffer (Pierce Biotechnologies, Rockford, CA, USA) using a
tissue lyser. Thereafter, the samples were centrifuged
(Eppendorf® MiniSpin® 5454 Micro centrifuge, Merck)
at 4 °C for 20 min at 12,000 rpm. Supernatant was col-
lected and stored at − 20 °C until required. Protein
(30 μg) was mixed with an equal volume of 2× Laemmli
sample buffer (Biorad) before it was denatured at 95 °C.
The denatured protein samples (30 μg) were loaded on
a 12% SDS-polyacrylamide gel (Bio-Rad, Hercules, CA,
USA) and transferred to a polyvinylidene fluoride
(PVDF) membrane (Bio-Rad, Hercules, CA, USA) [17]
and membranes containing the proteins of interest were
then incubated at 4 °C for 16 h with the following primary
antibodies: anti- IRS-1Ser307 (1:500), phospo-AktSer473
(1:1000), phospho-GSK-3βSer9 (1:1000) (Cell signaling,
Danvers, MA, USA), anti-GLUT 4 (1:1000) (Sigma-Aldrich
Chemical Co., St. Louis, MO, USA) and GLUT 2 (1:500)
(Sigma-Aldrich Chemical Co., St. Louis, MO, USA). Mem-
branes were then washed and incubated with the appropri-
ate horseradish peroxidase conjugated secondary antibody
at room temperature for 90 min. All proteins were normal-
ized to a loading control (β-Actin) (1:500) (Santa Cruz
Biotechnology, Dallas, TX, USA). Chemidoc-XRS imager
and Quantity One software (Bio-Rad Laboratories, Hercules,
CA, USA) were used to detect and quantify the proteins.
Image J software was used to quantify the signal intensity of
the bands.
Data analysis
Data were analyzed using GraphPad Prism software (ver-
sion 5.03). Experiments were performed in triplicates and
data were expressed as mean ± SEM. Statistical differences
between groups was determine by One-way analysis of
variance (ANOVA), followed by Tukey post-hoc test.
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The values were considered statistically significant where
p ≤ 0.05.
Results
Fasting blood glucose levels of the STZ-induced diabetic
rats
Table 1 shows the results of the effect of RA-3 on the
fasting blood glucose levels of the STZ-induced diabetic
rats following the experimental period of 28 days. Per-
sistently higher fasting plasma glucose levels were ob-
served in the diabetic control rats. However, treatment
of the diabetic rats with RA-3 significantly lowered the
blood glucose levels by 67%. The observed effect was
similar and comparable to the metformin treated group
(69%), which served as the positive control group.
Serum antioxidants and C-peptide levels
The effect of RA-3 on serum antioxidants and C-peptide
levels in the STZ-induced diabetic animals are presented
in Table 2. The STZ-induced type 1 diabetic rats showed a
significant decrease in GSH (4.31 ± 0.150, p ≤ 0.001), SOD
(29 ± 0.040, p ≤ 0.01), CAT (0.05 ± 0.006, p ≤ 0.05) and
C-peptide levels (0.5 ± 0.220, p ≤ 0.0001) when compared to
the normal control group. Treatment of the animals with
either RA-3 or metformin was able to significantly increase
the serum glutathione (6.05 ± 0.130, p ≤ 0.05), superoxide
dismutase (55 ± 0.011, p ≤ 0.05) catalase (0.10 ± 0.004, p ≤
0.05) and C-peptide (0.8 ± 1.020, p ≤ 0.0001) levels when
compared to their diabetic control counterparts.
Serum MDA and IL-6
The effect of RA-3 on the serum MDA and IL-6 levels
are presented in Fig. 2. The STZ-induced type 1 diabetic
rats showed a significant increase of serum MDA (270 ±
13.4%, p ≤ 0.0001) and IL-6 (153 ± 2.70%) when compared
to the normal control group. After 28 days of treatment, a
decreased in the levels of serum MDA (121 ± 12.5%, p ≤
0.0001) and IL-6 (135 ± 10.9%) was observed in the RA-3
treated group as compared to the diabetic control group.
This was consistent with the observed increase in antioxi-
dant levels in the RA-3 treated group. A similar and com-
parable effect was also observed in the metformin treated
group. However, the effect of either RA-3 or metformin to
reduce IL-6 levels was not significant.
Effect of RA-3 on the morphology of β-cells of the STZ-
induced diabetic rats
Histological evaluation of the pancreatic sections from
the different experimental groups was performed. The
results of the histology are shown in Fig. 3. The pancreas
of the normal rats (Fig. 3a) showed normal islet morph-
ology. Whereas the pancreatic tissues from the untreated
diabetic group (Fig. 3b) confirmed shrinkage of the islets.
However, treatment of the diabetic animals with RA-3 as
well as metformin appeared to preserve islet size as shown
in Fig. 3c and d, respectively.
Western blot analysis
IRS-1ser307, p-Akt, p-GSK-3β, GLUT 4 and GLUT 2 are
major proteins involved in the insulin-dependent signal-
ing pathway (Fig. 4). The results revealed that high blood
glucose levels in the untreated diabetic rats significantly
increased the expression of IRS-1Ser307 (183 ± 4.06%,
p ≤ 0.0001), while decreasing expression of p-AktSer473
(41 ± 0.91%, p ≤ 0.0001) and p-GSK-3β Ser9 (10 ± 2.71%,
p ≤ 0.0001) as compared to the non-diabetic group. The
observed effects of high blood glucose levels were reversed
following the 28 days treatment of the diabetic rats with
RA-3 (96 ± 2.61%, p ≤ 0.0001; 109 ± 3.14%, p ≤ 0.0001 and
94 ± 3.67%, p ≤ 0.0001, respectively) when compared to
the diabetic control group. The observed effects were
comparable to the metformin treated group. This study
showed that while a decrease in GLUT 4 (30 ± 3.97%, p ≤
0.0001) and GLUT 2 (40 ± 1.63%, p ≤ 0.0001) expression
Table 1 Results of the effect of RA-3 on fasting blood glucose
levels of the STZ-induced type 1 diabetic rats
Group Baseline
(mmol/L)
Blood glucose
levels
Day 28 (mmol/L)
ΔBlood
glucose
levels
(%)
Non-diabetic control 4.2 ± 0.22 4.3 ± 0.04
Diabetic control 14.0 ± 0.58**** 27.0 ± 1.14****
Diabetic + RA-3 13.3 ± 0.58**** 4.4 ± 0.44#### 67
Diabetic + metformin 13.8 ± 0.40**** 4.3 ± 0.44#### 69
Results are expressed as the mean ± SEM, n = 5. **** p ≤ 0.0001 versus non-
diabetic control, #### p ≤ 0.0001 versus diabetic control
Table 2 Effect of RA-3 on serum antioxidants and C-peptide levels of the diabetic animals
Group GSH
(nmol/mL)
SOD
(Inhibition rate %)
CAT
(Units/mL)
C-peptide
(μg/L)
Non-diabetic control 7.33 ± 0.010 56 ± 0.005 0.12 ± 0.005 0.8 ± 0.010
Diabetic control 4.31 ± 0.150*** 29 ± 0.040** 0.05 ± 0.006* 0.5 ± 0.220****
Diabetic + RA-3 6.05 ± 0.130*# 55 ± 0.011# 0.10 ± 0.004# 0.8 ± 1.020####
Diabetic + metformin 6.40 ± 0.140*# 54 ± 0.012# 0.10 ± 0.006# 0.8 ± 0.410####
Results are expressed as the mean ± SEM, n = 5. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001 versus non-diabetic control, # p ≤ 0.05, #### p ≤ 0.0001 versus
diabetic control
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was observed in the diabetic control group, an increased
expression (80 ± 8.16%, p ≤ 0.01) and (110 ± 3.14%, p ≤
0.01) of these proteins was observed in the skeletal muscle
and the liver tissues of the diabetic animals that received
RA-3 (Fig. 4d and e).
Discussion
Understanding the molecular mechanism that leads to the
development and progression of T1DM is an important ob-
jective in the management of the disease. Despite the use of
current hypoglycemic drugs and insulin injections to
manage the disease, the search for new drugs that can
prevent and/or effectively treat the disease is on-going.
Previous studies have demonstrated the anti-hyperglycemic
property of the lanosteryl triterpene (RA-3). This was evi-
denced by its ability to stimulate cellular glucose uptake in
C2C12 myocytes and 3 T3-1 L adipocytes [13] and then
improve glucose tolerance in diabetic rats [14, 15]. How-
ever, the molecular mechanism(s) through which RA-3 ex-
erts its hypoglycemic effect remained to be explored and
Fig. 2 Effect of RA-3 on serum (a) MDA and (b) IL-6 levels in STZ-induced type 1 diabetic animals. Results are expressed as the mean ± SEM, n =
5. * p≤ 0.05, ** p≤ 0.01, *** p≤ 0.001, **** p≤ 0.0001 vs. non-diabetic control, #### p≤ 0.0001 vs. diabetic control
Fig. 3 The effect of RA-3 on pancreatic islet morphology of STZ-induced type 1 diabetic rats. a Normal control group, (b) Untreated diabetic group, (c)
RA-3 treated group, and (d) Metformin treated group. (L) indicates a normal islet without any histological alterations, (E) exocrine portion of pancreatic
tissue and an arrow illustrates STZ-induced shrinkage of islets .NB: For each image the magnification (200X). Bar indicator is 60 μm
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understood. Thus, this study investigated potential of RA-3
to augment insulin signaling in the STZ-induced type 1 dia-
betic rats.
Insulin stimulates muscle glucose uptake by promoting
recruitment of GLUT 4 or GLUT 2 via activation of the
phosphatidylinositol 3-kinase (PI3-K) and Akt2 pathway
[6]. Under physiological conditions, an increase in the
expression of IR-IRS-PI3K-Akt signaling cascade is ob-
served. However, the expression of these proteins is down
regulated in the diabetic state. The results from the
current study showed that the hypoglycemic effect of
RA-3 could partly be linked to its ability to augment insu-
lin signalling (Fig. 5). This is indicated by the observed de-
crease in IRS-1Ser307 expression and increase in p-Akt and
p-GSK-3β expression, which was well correlated with the
increased expression of GLUT 4 and GLUT 2 in the RA-3
treated group. Increased expression of GLUT 4 and
GLUT 2 expression was further supported by the lower
blood glucose levels in the RA-3 treated diabetic ani-
mals. A pentacyclic triterpene, oleanolic acid, has also
been reported to enhance the insulin signaling pathway
in the skeletal muscle of STZ-induced diabetic rats
[18]. High expression of p-Akt activates translocation
of GLUT 4 and thus increases glucose uptake by the
cell. p-Akt also further phosphorylates GSK-3β, pro-
moting the glucose storage as glycogen. The ability of
RA-3 to increase the expression of p-GSK-3β shows po-
tential of this compound to control glucose homeosta-
sis. These results further support the previous report in
which RA-3 inhibited glucose-6-phosphatase and in-
creased hepatic glycogen storage in the STZ-induced
diabetic rats [14].
Fig. 4 Effect of RA-3 on the expression of IRS-1ser307 (a), p-AktSer473 (b), p-GSK-3β Ser9 (c), GLUT 4 (d) and GLUT 2 (e) in skeletal muscle tissues of
STZ-induced type 1 diabetic rats. Results are expressed as the mean ± SEM, n = 5. * p≤ 0.05, **** p≤ 0.0001 vs. non-diabetic control, ### p≤ 0.001,
#### p≤ 0.0001 vs. diabetic control
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Effective antidiabetic therapeutics should also possess
pancreatic β-cells protective properties in order to main-
tain their production of insulin. RA-3 also showed po-
tential to improve morphology of the pancreatic β-cells
of the diabetic rats. The potential β-cells protective ef-
fect of the triterpene could be attributed to its ability to
increase tissue antioxidant status which was evidenced
by increases in GSH, CAT and SOD serum levels in the
RA-3 treated group. The decrease in serum MDA levels,
a marker of lipid peroxidation, and IL-6 further sup-
ported the antioxidant protective potential of the com-
pound. The observed increase in serum C-peptide levels,
a reliable indicator of well-functioning pancreatic β-cells
[19], further supported the potential β-cells protective
effect of the triterpene. The ability of the lanosteryl tri-
terpene to improve pancreatic β-cells morphology and
thus increase serum C-peptide levels has recently been
demonstrated in type 2 diabetic rats [15]. Furthermore,
since oxidative stress and pro-inflammatory cytokines
such as IL-6 are implicated in the insulin signaling im-
pairment and β-cells dysfunction [20], the antioxidant
and anti-inflammatory effects mediated by RA-3 further
support its β-cells protective effect and stimulation of
cellular glucose uptake.
Conclusions
The present study provides evidence that the anti-hyper-
glycaemic activity of RA-3 could be linked to its ability
to protect pancreatic β-cells and improve insulin signal-
ing in skeletal muscles of the diabetic rats. This is indi-
cated by increased expression of proteins involved in
insulin signaling and eventual increased expression of
GLUT 4 in the muscle of the diabetic animals treated
with RA-3. The lanosteryl triterpene also reduced oxidative
stress and inflammation which are important mediators of
cellular insulin resistance, pancreatic β-cells dysfunction
and tissue damage in the diabetic animals. Thus, future
research directions, which are also important in addressing
limitations of the present study, involve immunohistochem-
istry of the skeletal muscle to confirm the effect of the
triterpene on the insulin signalling in skeletal muscle,
unravelling molecular mechanisms through which RA-3
improves the pancreatic islets size and quantification of
the number of islet cells in the diabetic rats. Furthermore,
the consistent similar results exhibited by RA-3 and met-
formin, a standard antidiabetic drug, suggests a need to
evaluate the antidiabetic effects of a combination of the
two drugs.
Abbreviations
Akt2: protein kinase B (2); GLUT 4: Glucose transporter 4; GLUTs: Glucose
transporters; GSK-3β: Glycogen synthase kinase 3 beta; IL-6: Interleukin-6;
IR: Insulin receptor; IRS-1: Insulin receptor substrate 1; PI3-K: Phosphatidylinositol
3-kinase; RA-3: Methyl-3β-hydroxylanosta-9,24-dien-21-oate; STZ: Streptozotocin;
T1DM: Type 1 diabetes mellitus
Acknowledgements
The authors are indebted to Zanka Yuroukova for her expertise in histopathological
analysis of the pancreatic tissue, the University of Zululand Research Committee
(UZRC) for funding this work and South African National Research Foundation
(NRF) for sponsorship awarded to M.S.E.
Funding
This work was financially supported by the University of Zululand Research
Committee (UZRC), South African National Research Foundation (SA-NRF)
and South African Medical Research Council’s Biomedical Research and
Innovation Platform.
Fig. 5 Overview of insulin regulation of major metabolic responses in the cells. Under physiological conditions, insulin binds to its receptor (IR) to
enhance positive tyrosine IRS-1 phosphorylation, promoting the activation of PI3-K which in turn phosphorylates and activates p-Akt. High
expression of p-Akt activates translocation of glucose transporter 4 and thus increasing glucose uptake by the cell. p-Akt also further
phosphorylates GSK-3β, promoting the glucose storage as glycogen. Under pathophysiological conditions, oxidative stress and pro-inflammatory
cytokines such as IL-6 enhance negative phosphorylation of IRS-1 serine (307), causing insulin resistance. Activated NF-KB activates serine/threonine
kinases (JNK) which phosphorylates IRS-1 and also works via other pathways such as SOCS expression to inhibit the insulin signaling pathway
Mabhida et al. BMC Complementary and Alternative Medicine          (2018) 18:265 Page 7 of 8
Availability of data and materials
All data generated or analysed during this study are included in this article
(However, supporting data are available from the corresponding author on
reasonable request).
Authors’ contributions
MRA and OA conceived and designed the experiments; MSE and SNF
performed the experiments; MRA, JR and JL experimental design and
interpretation of western blot analysis; MSE and NM analysed the data; OA,
MSE, JR and MRA wrote the manuscript. All authors have read and approved
the manuscript.
Ethics approval
Approval (ethical clearance number: UZREC 171110–030 PGM 2016/329) for
use of laboratory animals (rats) and experimental procedures was granted by
the University of Zululand research ethics committee (UZREC).
Consent for publication
“Not applicable”.
Competing interests
“The authors declare that they have no competing interests.”
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Department of Biochemistry and Microbiology, University of Zululand,
Private Bag X1001, KwaDlangezwa 3886, South Africa. 2Biomedical Research
and Innovation Platform (BRIP), South African Medical Research Council,
Tygerberg 7505, South Africa. 3Division of Medical Physiology, Faculty of
Medicine and Health Sciences, Stellenbosch University, Tygerberg 7505,
South Africa.
Received: 13 July 2018 Accepted: 25 September 2018
References
1. World health Organization (WHO). World health statistics 2017. Available
online: http://apps.who.int/iris/bitstream/10665/44844/1/9789241564441_
eng.pdf?ua=1 (accessed on 29 May 2017).
2. Wherrett D, Huot C, Mitchell B, Pacaud D. Type 1 diabetes in children and
adolescents. Can J Diabetes. 2013;37:153–62.
3. Centers for Disease Control and Prevention. National diabetes statistics
report, 2017. Atlanta, GA: Centers for Disease Control and Prevention, US
Department of Health and Human Services; 2017.
4. International Diabetes Federation (IDF). IDF Diabetes Atlas, 7th ed. Available
online: http://www.diabetesatlas.org/ (accessed on 29 May 2017).
5. Wei Y, Chen K, Whaley-Connell AT, Stump CS, Ibdah JA, Sowers JR. Skeletal
muscle insulin resistance: role of inflammatory cytokines and reactive
oxygen species. Am J Phys Regul Integr Comp Phys. 2008;294(3):673–80.
6. Li X, Wang F, Xu M, Howles P, Tso P. ApoA-IV improves insulin sensitivity
and glucose uptake in mouse adipocytes via PI3K-Akt signaling. Sci Rep.
2017;7:216–26.
7. Solinas G, Becattini B. JNK at the crossroad of obesity, insulin resistance, and
cell stress response. Molecular Metabolism. 2017;6(2):174.
8. Hou W, Li Y, Zhang Q, Wei X, Peng A, Chen L, Wei Y. Triterpene acids
isolated from Lagerstroemia speciosa leaves as α-glucosidase inhibitors.
Phytother Res. 2009;23(5):614–8.
9. Musabayane CT, Tufts MA, Mapanga RF. Synergistic antihyperglycemic
effects between plant-derived oleanolic acid and insulin in streptozotocin-
induced diabetic rats. Ren Fail. 2010;32(7):832–9.
10. Khathi A, Serumula MR, Myburg RB, Van Heerden FR, Musabayane CT.
Effects of Syzygium aromaticum-derived triterpenes on postprandial blood
glucose in streptozotocin-induced diabetic rats following carbohydrate
challenge. PLoS One. 2013;8(11):81632.
11. Lee MS, Thuong PT. Stimulation of glucose uptake by triterpenoids from
Weigela subsessilis. Phytother Res. 2010;24(1):49–53.
12. Castellano JM, Guinda A, Delgado T, Rada M, Cayuela JA. Biochemical basis
of the antidiabetic activity of oleanolic acid and related pentacyclic
triterpenes. Diabetes. 2013;62(6):1791–9.
13. Mosa RA, Naidoo JJ, Nkomo FS, Mazibuko SE, Muller CJF, Opoku AR. In vitro
anti-hyperlipidemic potential of triterpenes from stem bark of Protorhus
longifolia. Planta Med. 2014;80:1685–91.
14. Mosa RA, Cele ND, Mabhida SE, Shabalala SC, Penduka D, Opoku AR. In vivo
antihyperglycemic activity of a lanosteryl triterpene from Protorhus
longifolia. Molecules. 2015;20:13374–83.
15. Mabhida SE, Mosa RA, Penduka D, Osunsanmi FO, Dludla PV, Djarova TG,
Opoku AR. A lanosteryl triterpene from Protorhus longifolia improves
glucose tolerance and pancreatic beta cell ultrastructure in type 2 diabetic
rats. Molecules. 2017;22(8):1252.
16. Machaba KE, Cobongela SZZ, Mosa RA, Lawal AO, Djarova TG, Opoku AR. In
vivo anti-hyperlipidemic activity of the triterpene from the stem bark of
Protorhus longifolia (Benrh) Engl. Lipids Health Dis. 2014;13:131.
17. Johnson R, Shabalala S, Louw J, Kappo AP, Muller CJF. Aspalathin reverts
doxorubicin-induced cardiotoxicity through increased autophagy and
decreased expression of p53/mTOR/p62 signaling. Molecules. 2017;22(10):1589.
18. Mukundwa A, Mukaratirwa S, Masola B. Effects of oleanolic acid on the
insulin signaling pathway in skeletal muscle of streptozotocin-induced
diabetic male Sprague-Dawley rats. J Diabetes. 2016;8(1):98–108.
19. Leighton E, Sainsbury CA, Jones GC. A practical review of C-peptide testing
in diabetes. Diabetes Therapy. 2017;5:1–13.
20. Elmarakby AA, Sullivan JC. Relationship between oxidative stress and
inflammatory cytokines in diabetic nephropathy. Cardiovasc Ther.
2012;30:49–59.
Mabhida et al. BMC Complementary and Alternative Medicine          (2018) 18:265 Page 8 of 8
